Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1731-1737

  Taylor, David A ^a   Jensen, Marianne W ^a   Aikman, Sarah L ^a   Harris, Jeanette G ^a   Barnes, Peter J ^a   O'Connor, Brian J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HISTAMINE; METHACHOLINE; SALBUTAMOL; SALMETEROL;

ADULT; AIRWAY DYNAMICS; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS MUSCLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; MAST CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE;

EID: 0031464177     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.9703047     Document Type: Article

References (33)

1. Nelson, H. S. 1997. β-adrenergic bronchodilators. N. Engl. J. Med. 333: 499-506.
2. 2 agonists: greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 150:381-387.
3. O'Byrne, P. M., M. Morris, R. Roberts, and F. E. Hargreave. 1982. Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline sulphate. Thorax 37:913-917.
4. Cockcroft, D. W., and K. Y. Murdock. 1987. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 79:734-740.
5. 2 agonists in asthma. N. Engl. J. Med. 327:1204-1208.
6. 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5′-monophosphate in asthma. J. Allergy Clin. Immunol. 85:755-762.
7. Egbagbe, E., I. D. Pavord, P. Wilding, J. Thompson-Coon, and A. E. Tattersfield. 1997. Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax 52:239-243.
8. Cushley, M. J., and S. T. Holgate. 1985. Adenosine-induced bronchoconstriction in asthma: role of mast cell mediator release. J. Allergy Clin. Immunol. 75:272-278.
9. Bjorck, T., L. E. Gustafsson, and S. E. Dahlen. 1992. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am. Rev. Respir. Dis. 145:1087-1091.
10. 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674-678.
11. Butchers, P. R., C. J. Vardey, and M. Johnson. 1991. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J Pharmacol. 104:672-676.
12. Nials, A. T., D. I. Ball, P. R. Butchers, R. A. Coleman, A. A. Humbles, M. Johnson, and C. J. Vardey. 1994. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur. J. Pharmacol. 251:127-135.
13. Soler, M., L. Joos, C. T. Bolliger, S. Elsasser, and A. P. Perruchoud. 1994. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction. Eur. Respir. J. 7:1973-1977.
14. Glantz, S. A. 1997. Primer of Biostatistics. 4th ed. McGraw-Hill, New York.
15. 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax 46:9-14.
16. 2-agonists on methacholine dose-response curves in asthmatics. Eur. Respir. J. 10:330-336.
17. Church, M. K., and J. Hiroi. 1987. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmacol. 90:421-429.
18. Tattersfield, A. E. 1985. Effect of beta-agonists and anticholinergic drugs on bronchial reactivity. Am. Rev. Respir. Dis. 136:S64-S68.
19. Derom, E. Y., R. A. Pauwels, and M. E. F. Van Der Straeten. 1992. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J. Allergy Clin. Immunol. 89:811-815.
20. Coulby, L. J., D. L. Smith, S. L. Aikman, J. M. Sutcliffe, and B. J. O'Connor. 1995. The protective effect of salmeterol on airway responsiveness to methacholine: comparison between metered dose inhalers containing either CFC-free propellant GRI06642X or propellant 11 and 12 (abstract). Am. J. Respir. Crit. Care Med. 151:A56.
21. 2-adrenergic receptor. J. Biol. Chem. 271:24029-24035.
22. Chong, L. K., A. H. Morice, W. W. Yeo, R. P. Schleimer, and P. T. Peachell. 1995. Functional desensilization of β agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol. 13:540-546.
23. Larson, P. T., A. Martinsson, G. Olsson, and P. Hjemdahl. 1989. Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues. Br. J. Clin. Pharmacol. 28:663-674.
24. Krall, J. F., M. Connelly, and M. L. Tuck. 1980. Acute regulation of beta-adrenergic catecholamine sensitivity in human lymphocytes. J. Pharmacol. Exp. Ther. 214:554-560.
25. Lipworth, B. J., A. D. Struthers, and D. G. McDevitt. 1989. Tachyphylaxis to systemic but not airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am. Rev. Respir. Dis. 140:586-592.
26. Hughes, J. M., J. P. Seale, and D. M. Temple. 1983. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by β-adrenoceptor antagonists. Eur. Respir. J. 95:239-245.
27. 4 excretion. J. Allergy Clin. Immunol. 89:575-583.
28. 2-adrenoceptor agonist, salmeterol on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
29. Booth, H., J. Walters, and E. H. Walters. 1996. Salmeterol tachyphylaxis in steroid treated asthmatic patients. Thorax 51:1100-1104.
30. Bhagat, R., S. Kalra, V. A. Swystun, and D. W. Cockcroft. 1995. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 108:1235-1239.
31. Rabe, K. F., M. A. Giembycz, R. S. Perkins, P. Evans, and P. J. Barnes. 1993. Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. Eur. J. Pharmacol. 231:305-308.
32. 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur. Respir. J. 4: 218-226.
33. Twentyman, O. P., J. P. Finnerty, A. Harris, J. Palmer, and S. T. Holgate. 1990. Protection against allergen-induced asthma by salmeterol. Lancet 336:1338-1342.